Review ASHP’s revised Guidelines on Preventing Diversion of Controlled Substances, outlining the latest strategies to help healthcare organizations develop and implement a collaborative, comprehensive controlled substance diversion prevention program.
This webinar features Samantha Roberts, Director of Pharmacy Regulatory and Compliance at Emory Healthcare.
What you'll learn
- What’s new and improved in ASHP’s revised Guidelines on Preventing Diversion of Controlled Substances
- Emory Healthcare’s experience implementing these guidelines, with suggestions and best practices for your health system.
- Why these guidelines now strongly recommend the use of diversion monitoring software with advanced analytics capability to support monitoring and surveillance activities.
